Clinical Trial 37851

Northridge, CA 91324


Summary:

Tralokinumab monotherapy for treating moderate-to-severe atopic dermatitis


Qualified Participants Must:

• Have moderate to severe atopic dermatitis covering 10% of their bodies or more
• Be 18 years of age or older


Qualified Participants May Receive:

Free study related care and treatment; compensation for their time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.